Pycnogenol® in Metabolic Syndrome and Related Disorders (Q38452746)

3 September 2017

1 reference

title

Pycnogenol® in Metabolic Syndrome and Related Disorders (English)

1 reference

3 September 2017

1 reference

Om P Gulati

1

1 reference

3 September 2017

publication date

1 May 2015

1 reference

3 September 2017

published in

Phytotherapy Research

1 reference

3 September 2017

volume

29

1 reference

3 September 2017

issue

7

1 reference

3 September 2017

page(s)

949-968

1 reference

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

3 September 2017

cites work

1 reference

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

The nitric oxide-endothelin-1 connection

21 January 2018

1 reference

Metabolic syndrome and oxidative stress

21 January 2018

1 reference

Association between albuminuria and proteinuria in the general population: the AusDiab Study.

21 January 2018

1 reference

Pycnogenol accelerates wound healing and reduces scar formation

21 January 2018

1 reference

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

21 January 2018

1 reference

Essential hypertension : part II: treatment

21 January 2018

1 reference

Essential Hypertension : Part I: Definition and Etiology

21 January 2018

1 reference

Possible role of oxidative stress in the pathogenesis of hypertension

21 January 2018

1 reference

Improvement in circulation and in cardiovascular risk factors with a proprietary isotonic bioflavonoid formula OPC-3.

21 January 2018

1 reference

Kidney flow and function in hypertension: protective effects of pycnogenol in hypertensive participants--a controlled study

21 January 2018

1 reference

The metabolic syndrome and chronic kidney disease in U.S. adults

21 January 2018

1 reference

21 January 2018

The metabolic syndrome

1 reference

Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention

21 January 2018

1 reference

Genes, diet and type 2 diabetes mellitus: a review

21 January 2018

1 reference

Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile

21 January 2018

1 reference

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis.

21 January 2018

1 reference

Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol).

21 January 2018

1 reference

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

Pycnogenol® in chronic venous insufficiency and related venous disorders

21 January 2018

1 reference

Role of renin in the pathogenesis of renal hypertension

21 January 2018

1 reference

Obesity: pathophysiology and clinical management

21 January 2018

1 reference

Endothelin as a regulator of cardiovascular function in health and disease

21 January 2018

1 reference

Effects of a medical food containing an herbal alpha-glucosidase inhibitor on postprandial glycemia and insulinemia in healthy adults.

21 January 2018

1 reference

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

Hypertension, hypertensive heart disease and perioperative cardiac risk

21 January 2018

1 reference

Effects of black raspberry on lipid profiles and vascular endothelial function in patients with metabolic syndrome.

21 January 2018

1 reference

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes

21 January 2018

1 reference

Genetics of non-insulin-dependent (type-II) diabetes mellitus

21 January 2018

1 reference

Inhibitory effect of pine extract on alpha-glucosidase activity and postprandial hyperglycemia

21 January 2018

1 reference

The role of inflammatory cytokines in diabetes and its complications

21 January 2018

1 reference

Therapeutic potential of anti-oxidants and diabetic retinopathy

21 January 2018

1 reference

Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study

21 January 2018

1 reference

Pycnogenol as an adjunct in the management of childhood asthma

21 January 2018

1 reference

Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension

21 January 2018

1 reference

Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients

21 January 2018

1 reference

Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II.

21 January 2018

1 reference

French maritime pine bark extract Pycnogenol dose-dependently lowers glucose in type 2 diabetic patients

21 January 2018

1 reference

Practical considerations of the pharmacology of angiotensin receptor blockers

21 January 2018

1 reference

Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation, and hydroxyl radical-induced DNA damage.

21 January 2018

1 reference

Effects of propranolol on the development of renovascular hypertension in the rat

21 January 2018

1 reference

Effects of lifestyle intervention in persons at risk for type 2 diabetes mellitus - results from a randomised, controlled trial

21 January 2018

1 reference

Protective effects of pycnogenol against ischemia reperfusion-induced oxidative renal injury in rats

21 January 2018

1 reference

Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol

21 January 2018

1 reference

Pycnogenol prevents potassium dichromate K2Cr2O7-induced oxidative damage and nephrotoxicity in rats

21 January 2018

1 reference

Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats

21 January 2018

1 reference

Pycnogenol inhibits tumor necrosis factor-alpha-induced nuclear factor kappa B activation and adhesion molecule expression in human vascular endothelial cells

21 January 2018

1 reference

Inhibition of smoking-induced platelet aggregation by aspirin and pycnogenol

21 January 2018

1 reference

Effect of procyanidins from Pinus maritima on glutathione levels in endothelial cells challenged by 3-morpholinosydnonimine or activated macrophages

21 January 2018

1 reference

A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology

21 January 2018

1 reference

Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract

21 January 2018

1 reference

Oligomeric procyanidins of French maritime pine bark extract (Pycnogenol) effectively inhibit alpha-glucosidase

21 January 2018

1 reference

Pathophysiology of type 2 diabetes

21 January 2018

1 reference

Obesity, essential hypertension and renin-angiotensin system

21 January 2018

1 reference

Pycnogenol improves microcirculation, retinal edema, and visual acuity in early diabetic retinopathy

21 January 2018

1 reference

Treatment of dyslipoproteinemia in the metabolic syndrome

21 January 2018

1 reference

Assessment of the cytotoxic, genotoxic, and antigenotoxic potential of Pycnogenol® in in vitro mammalian cells

21 January 2018

1 reference

Role of endothelin in human hypertension

21 January 2018

1 reference

Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans

21 January 2018

1 reference

Procyanidins extracted from pine bark protect alpha-tocopherol in ECV 304 endothelial cells challenged by activated RAW 264.7 macrophages: role of nitric oxide and peroxynitrite

21 January 2018

1 reference

Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients

21 January 2018

1 reference

Differential impact of metabolic syndrome on arterial stiffness and wave reflections: focus on distinct definitions

21 January 2018

1 reference

Salt sensitivity of blood pressure in humans

21 January 2018

1 reference

Effects of a specific and long-acting renin inhibitor in the marmoset

21 January 2018

1 reference

Protective effects of Pycnogenol on carbon tetrachloride-induced hepatotoxicity in Sprague-Dawley rats

21 January 2018

1 reference

Lipid-lowering effects of curcumin in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries

21 January 2018

1 reference

Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation

21 January 2018

1 reference

Reducing the risk of type 2 diabetes with nutrition and physical activity – efficacy and implementation of lifestyle interventions in Finland

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PTR.5341

1 reference

3 September 2017

1 reference